Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract Infection
Sulopenem was noninferior to amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection, but was associated with more frequent mild adverse events. (Funded by Iterum Therapeutics; REASSURE ClinicalTrials.gov number, NCT05584657.).
Authors
- Sailaja Puttagunta
- Michael W. Dunne (ORCID: https://orcid.org/0000-0001-6186-5196)
- Steven I. Aronin (ORCID: https://orcid.org/0000-0002-4041-043X)
- Jayanti Gupta
- Anita Das
- Kalpana Gupta (ORCID: https://orcid.org/0000-0002-6766-3576)
Institutions
- Boston University (US)
- Fulcrum Therapeutics (United States) (US)
- West County Health Centers (US)
Publication Details
- Journal
- NEJM Evidence
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1056/evidoa2400414
- Citations
- 6
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 8.13